Arkolith/Insider Trading/FSTX/Form 4

Brewis Neil

Chief Scientific OfficerF-star Therapeutics, Inc. (FSTX) · full profile →Form 4 · filed Aug 2, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 29, 2022Option exercise(M)77K$0.11$8K114K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 29, 2022Option exercise(M)6K—$00
Jul 29, 2022Option exercise(M)70K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-044006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML